Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration

Drug Testing and Analysis

Volumn 9, Issue 6, 2017, Pages 905-915

  Swortwood, Madeleine J ^a   Newmeyer, Matthew N ^a,b   Andersson, Maria ^a   Abulseoud, Osama A ^a   Scheidweiler, Karl B ^a   Huestis, Marilyn A ^a,c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

cannabinoids; edibles; oral fluid; smoking; vaporizer

Indexed keywords

CONTROLLED DRUG DELIVERY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; VAPORIZATION;

CANNABINOIDS; DETECTION WINDOWS; EDIBLE; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MATRIX; OH -; ORAL FLUIDS; ORAL ROUTE; SMOKING; VAPORIZER;

PHARMACOKINETICS;

CANNABIDIOL; CANNABIGEROL; CANNABINOID; CANNABIS; DRONABINOL; PLACEBO; TETRAHYDROCANNABINOLIC ACID; TETRAHYDROCANNABIVARIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY FLUID; CANNABIS SMOKING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLITE; MIDDLE AGED; MOUTH MUCOSA; NORMAL HUMAN; ORAL FLUID; PHARMACOKINETICS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SMOKING; TANDEM MASS SPECTROMETRY; VAPOR; VAPORIZATION; YOUNG ADULT; CHEMISTRY; METABOLISM; ORAL DRUG ADMINISTRATION; SALIVA; SUBSTANCE ABUSE; VOLATILIZATION;

ADMINISTRATION, ORAL; ADULT; CANNABINOIDS; CANNABIS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; SALIVA; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; VOLATILIZATION; YOUNG ADULT;

EID: 84991407728     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.2092     Document Type: Article

References (37)

1. United Nations. World Drug Report 2015, United Nations, Vienna, 2015.
2. A. Berning, R. Compton, K. Wochinger. Results of the 2013-2014 National Roadside Survey of Alcohol and Drug Use by Drivers. Traffic Safety Facts: Research Note. National Highway Traffic Safety Administration, Washington, DC, 2015.
3. M. Asbridge, R. Mann, M. D. Cusimano, C. Trayling, M. Roerecke, J. M. Tallon, A. Whipp, J. Rehm. Cannabis and traffic collision risk: findings from a case-crossover study of injured drivers presenting to emergency departments. Int. J. Public Health. 2014, 59, 395.
4. M.-C. Li, J. E. Brady, C. J. DiMaggio, A. R. Lusardi, K. Y. Tzong, G. Li. Marijuana use and motor vehicle crashes. Epidemiol. Rev. 2011, 34, 65.
5. J. G. Ramaekers, G. Berghaus, M. van Laar, O. H. Drummer. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004, 73, 109.
6. R. L. Hartman, M. A. Huestis. Cannabis effects on driving skills. Clin. Chem. 2013, 59, 478.
7. T. Van der Linden, S. A. Legrand, P. Silverans, A. G. Verstraete. DUID: oral fluid and blood confirmation compared in Belgium. J. Anal. Toxicol. 2012, 36, 418.
8. N. Samyn, G. De Boeck, A. G. Verstraete. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J. Forensic Sci. 2002, 47, 1380.
9. S. Strano-Rossi, E. Castrignano, L. Anzillotti, G. Serpelloni, R. Mollica, F. Tagliaro, J. P. Pascali, D. di Stefano, R. Sgalla, M. Chiarotti. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5 + ® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis. Forensic Sci. Int. 2012, 221, 70.
10. T. Blencowe, A. Pehrsson, P. Lillsunde, K. Vimpari, S. Houwing, B. Smink, R. Mathijssen, T. Van der Linden, S. A. Legrand, K. Pil, A. Verstraete. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Sci. Int. 2011, 208, 173.
11. V. Vindenes, H. M. Lund, W. Andresen, H. Gjerde, S. E. Ikdahl, A. S. Christophersen, E. L. Øiestad. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci. Int. 2012, 219, 165.
12. M. Concheiro, A. de Castro, O. Quintela, A. Cruz, M. López-Rivadulla. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing. Forensic Sci. Int. 2007, 170, 156.
13. R. Hartman, S. Anizan, M. Jang, T. L. Brown, K. Yun, D. Gorelick, G. Milavetz, A. Spurgin, G. Gaffney, M. Huestis. Cannabinoid disposition in oral fluid after controlled vaporizer administration with and without alcohol. Forensic Toxicol. 2015.
14. G. L. Schauer, B. A. King, R. E. Bunnell, G. Promoff, T. A. McAfee. Toking, vaping, and eating for health or fun: marijuana use patterns in adults, USA, 2014. Am. J. Prev. Med. 2016, 50, 1.
15. S. Anizan, G. Milman, N. Desrosiers, A. J. Barnes, D. A. Gorelick, M. A. Huestis. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Anal. Bioanal. Chem. 2013, 405, 8451.
16. M. N. Newmeyer, N. A. Desrosiers, D. Lee, D. R. Mendu, A. J. Barnes, D. A. Gorelick, M. A. Huestis. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug Test. Anal. 2014, 6, 1002.
17. R. Niedbala, K. Kardos, D. Fritch, S. Kardos, T. Fries, J. Waga, J. Robb, E. Cone. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J. Anal. Toxicol. 2001, 25, 289.
18. 9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J. Anal. Toxicol. 2010, 34, 216.
19. D. Lee, D. M. Schwope, G. Milman, A. J. Barnes, D. A. Gorelick, M. A. Huestis. Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin. Chem. 2012, 58, 748.
20. D. Lee, R. Vandrey, D. R. Mendu, J. A. Murray, A. J. Barnes, M. A. Huestis. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug Test. Anal. 2015, 7, 494.
21. J. M. Mitchell, E. J. Cone, R. Flegel, C. LoDico, E. S. Herrmann, G. E. Bigelow, R. Vandrey. Oral administration of cannabis in brownies. Society of Forensic Toxicologists Annual Meeting, Atlanta, GA, USA, 2015.
22. H. Schulze, M. Schumacher, R. Urmeew, K. Auerbach, J. Alvarez, I. M. Bernhoft, H. de Gier, M. Hagenzieker, S. Houwing, A. Knoche, M. Pilgerstorfer, B. Zlender. Driving Under the Influence of Drugs, Alcohol and Medicines in Europe – finding from the DRUID project. EMCDDA, Lisbon, 2012.
23. S. A. a. M. H. S. Administration. Mandatory Guidelines for Federal Workplace Drug Testing Programs. Federal Register 2015, 80 28054.
24. D. Lee, G. Milman, D. M. Schwope, A. J. Barnes, D. A. Gorelick, M. A. Huestis. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin. Chem. 2012, 58, 1101.
25. S. Anizan, M. M. Bergamaschi, A. J. Barnes, G. Milman, N. Desrosiers, D. Lee, D. A. Gorelick, M. A. Huestis. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis. Drug Test. Anal. 2014, 7, 114.
26. N. A. Desrosiers, K. B. Scheidweiler, M. A. Huestis. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry. Drug Test. Anal. 2015, 7, 684.
27. C. Moore, S. Rana, C. Coulter, D. Day, M. Vincent, J. Soares. Detection of conjugated 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J. Anal. Toxicol. 2007, 31, 187.
28. M. Vondracek, Z. Xi, P. Larsson, V. Baker, K. Mace, A. Pfeifer, H. Tjälve, M. T. Donato, M. J. Gomez-Lechon, R. C. Grafström. Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis. 2001, 22, 481.
29. S.-P. Yang, G. M. Raner. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. Toxicol. Appl. Pharmacol. 2005, 202, 140.
30. P. G. Sacks, Z.-L. Zhao, W. Kosinska, K. E. Fleisher, T. Gordon, J. B. Guttenplan. Concentration dependent effects of tobacco particulates from different types of cigarettes on expression of drug metabolizing proteins, and benzo(a)pyrene metabolism in primary normal human oral epithelial cells. Food Chem. Toxicol. 2011, 49, 2348.
31. L. X. Zhou, B. Pihlstrom, J. P. Hardwick, S. S. Park, S. A. Wrighton, J. L. Holtzman. Metabolism of phenytoin by the gingiva of normal humans: the possible role of reactive metabolites of phenytoin in the initiation of gingival hyperplasia. Clin. Pharmacol. Ther. 1996, 60, 191.
32. A. Hazekamp, R. Ruhaak, L. Zuurman, J. van Gerven, R. Verpoorte. Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol. J. Pharm. Sci. 2006, 95, 1308.
33. G. Milman, A. Barnes, D. Schwope, E. Schwilke, R. Goodwin, D. Kelly, D. Gorelick, M. Huestis. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Anal. Bioanal. Chem. 2011, 401, 599.
34. G. Milman, A. J. Barnes, D. M. Schwope, E. W. Schwilke, W. D. Darwin, R. S. Goodwin, D. L. Kelly, D. A. Gorelick, M. A. Huestis. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin. Chem. 2010, 56, 1261.
35. E. Hidvegi, G. P. Somogyi. Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption. Pharmazie. 2010, 65, 408.
36. M. A. ElSohly, S. Feng, T. P. Murphy, A. W. Warrington, S. Ross, A. Nimrod, Z. Mehmedic, N. Fortner. Identification and quantitation of 11-nor-delta-tetrahydrocannabivarin-9-carboxylic acid, a major metabolite of delta-tetrahydrocannabivarin. J. Anal. Toxicol. 2001, 25, 476.
37. 9-Tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. Drug Alcohol Depend. 2010, 106, 65.